Der-Yuan Chen

36PUBLICATIONS
46CO-AUTHORS
Respiratory diseasesHaematological tumoursRheumatology and arthritisInfectious agentsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 11, 2026
The presence of anti-Ro52/SSA antibodies may predict concomitant pulmonary hypertension and poorer survival in patients with connective tissue disease-associated interstitial lung disease.

|Feb 26, 2026
Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.

Chung-Mao Kao, Po-Cheng Shih, Der-Yuan Chen

|Jan 16, 2026
The Taiwan College of Rheumatology Consensus for the Management of Systemic Lupus Erythematosus.

Wen-Nan Huang, Ming-Han Chen, Song-Chou Hsieh

|Dec 30, 2025
Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case-Control Study.

Der-Yuan Chen, Ching-Heng Lin, Hsin-Hua Chen

|Mar 13, 2025
Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide, population-based cohort study.

Chung-Mao Kao, Yen-Ju Chen, Yi-Ming Chen

|Jan 01, 2025
Inhibiting Tyrosine Kinase 2 Ameliorates Antiphospholipid Syndrome Nephropathy.

Kuo-Tung Tang, Yu-Sin Chen, Tzu-Ting Chen

Pageof 6

Frequent Collaborators

13 joint publications

Hsin-Hua Chen

10 joint publications

Kuo-Tung Tang

5 joint publications

Yi-Ming Chen

4 joint publications

Tsai-Ling Liao